The report by Allied Market Research states that the global 3D cell culture market garnered $765 million in 2015, and is expected to reach $4.69 billion by 2022, registering a CAGR of 29.4% from 2016 to 2022. Cancer research segment contributed nearly one-third of the total market share in terms of revenue in 2015.
Factors that drive the global 3D cell culture market are technological advancements including development of improved scaffold-free & scaffold-based products, rise in research and development activities, and growth in demand for organ transplantations. Moreover, the collaborations between hospitals, companies, and academic institutions resulted in the launch of new products, which boosts the market growth. Stringent regulations on usage of animal models for diagnostic tests supplement the growth of the market. On the other hand, scarcity of skilled professionals and budgetary constraints related to research-related activities hinder the growth in the market.
Download Sample Report @ https://www.alliedmarketresearch.com/request-sample/1474
The cancer research segment is expected to maintain its lead position throughout the analysis period. This is due to behavior related to the cancer cells that grow in 3D culture is same as the cells that grow in vivo. Therefore, 3D cell culture enables researchers to examine tumor characteristics including dormancy, hypoxia, and anti-apoptotic behavior. The R&D activities conducted in oncology have grown at fast pace, owing to the different advantages offered by 3D cell culture.
North America accounted for the highest market share in the 3D cell culture market, contributing around two-fifths of the total market share in 2015, and is estimated to continue its dominance throughout the forecast period. Advancements in different healthcare applications including cancer and tissue engineering drive the market growth in the region. For instance, a miniature lattice structure called AngioChip was developed by a Canadian scientist created in 2016. It is expected to be used for development of human tissues outside the body. This person-on-a-chip technology is useful for determining the side effects of drugs on human tissues.
Key findings of the study:
- Among product types, the micro-chips segment is expected to register the highest growth rate during the forecast period.
- Republic of South Africa would register a CAGR of 28.4% during the forecast period.
- Cancer research application contributed the highest share in the global 3D cell culture market throughout the forecast period.
- The U.S. held the largest market share in 2015, and is estimated to maintain its lead position by 2022.
- The academic institutes segment is expected to dominate by 2022.
Key players analyzed in the report include Advanced Biomatrix, Inc., 3D Biotek, LLC, Corning Incorporated, Becton, Dickinson, and Company, Lonza Group Ltd., Kuraray Co., Ltd., Synthecon, Incorporated, Merck & Co., Inc., Thermo Fisher Scientific Inc., and VWR Corporation.
Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060